{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T17:16:54Z","timestamp":1720372614544},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81271833","81071354","81101241","81201277"],"award-info":[{"award-number":["81271833","81071354","81101241","81201277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Science and Technology Special Project of China","award":["2012ZX10002007-001-002","2013ZX10002001"],"award-info":[{"award-number":["2012ZX10002007-001-002","2013ZX10002001"]}]},{"name":"Major Research and Development Project of Innovative Drugs, Ministry of Science and Technology","award":["2012ZX09303004-001"],"award-info":[{"award-number":["2012ZX09303004-001"]}]},{"name":"973 Project","award":["2012CB519001"],"award-info":[{"award-number":["2012CB519001"]}]},{"name":"Renovation Fund of the Science & Technology commission of Shanghai Municipality","award":["11DZ2291900"],"award-info":[{"award-number":["11DZ2291900"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jviromet.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T03:31:18Z","timestamp":1393558278000},"page":"51-56","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus"],"prefix":"10.1016","volume":"201","author":[{"given":"Yijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyue","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2014.02.008_bib0005","first-page":"13","article-title":"The guideline of prevention and treatment for chronic hepatitis B (2010 version)","volume":"19","year":"2011","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2012.09.014","article-title":"Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States","volume":"58","author":"Baxa","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0020","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"Brunelle","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0025","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.21422","article-title":"Entecavir resistance is rare in nucleoside naive patients with hepatitis B","volume":"44","author":"Colonno","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0030","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejca.2010.03.034","article-title":"Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections","volume":"46","author":"De Mitri","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0035","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3851\/IMP1551","article-title":"Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?","volume":"15","author":"Durantel","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0045","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.44.12.3402-3407.2000","article-title":"Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus","volume":"44","author":"Fu","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/JVI.01921-09","article-title":"Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/jmv.21593","article-title":"Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2","volume":"81","author":"Huang","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0060","first-page":"65","article-title":"The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues","volume":"9","author":"Ladner","year":"1998","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/368083","article-title":"Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B","volume":"36","author":"Lai","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0070","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.gastro.2005.05.053","article-title":"A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B","volume":"129","author":"Lai","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0075","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00236-10","article-title":"Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S\/S RNAs","volume":"84","author":"Li","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0080","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0085","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JVI.01998-10","article-title":"Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells","volume":"85","author":"Mao","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0090","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/j.1365-2893.2011.01435.x","article-title":"Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B","volume":"18","author":"Mirandola","year":"2011","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23722","article-title":"Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels","volume":"52","author":"Rijckborst","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/jhep.2002.35070","article-title":"Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses","volume":"36","author":"Seigneres","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0105","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1756-9966-28-58","article-title":"Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1","volume":"28","author":"Tian","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2006.08.013","article-title":"Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient","volume":"131","author":"Villet","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2893.2005.00578.x","article-title":"Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients","volume":"12","author":"Westland","year":"2005","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/135965350501000507","article-title":"Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV","volume":"10","author":"Yang","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2006-939759","article-title":"In vitro models for studying hepatitis B virus drug resistance","volume":"26","author":"Zoulim","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jviromet.2014.02.008_bib0135","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2014.02.008_bib0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jir282","article-title":"Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss","volume":"204","author":"Zoutendijk","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093414000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093414000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T17:04:55Z","timestamp":1689008695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093414000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":28,"alternative-id":["S0166093414000512"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2014.02.008","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}